NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

ABMD | NASDAQ

$381.02 $0.00 | 0.00%
TREND SIGNAL:Signal available — unlock to view |2022-11-11
Add to favoritesFavorite

Company Overview:

Market Cap: $0
Trailing PE: —
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $0.00 - $0.00

10 Year ABMD Performance Metrics:

Total Return (with DRIP): 262.9% (13.76% CAGR)
Total Return (no DRIP): 262.9% (13.76% CAGR)
Share Price: 262.4% (13.74% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $36,291
Total Return $ (with DRIP): $26,291
ABMD Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
ABMD Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
Build Custom Charts
ABMD - Chart 1
ABMD - Chart 2
ABMD - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

ABMD Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

ABMD - Revenue
ABMD Revenue CAGR:1Y: 7.16%2Y: 12.59%5Y: 14.89%10Y: 21.67%
ABMD - Earnings Per Share (EPS)
ABMD EPS CAGR:1Y: 87.10%2Y: 30.61%5Y: 33.85%10Y: 33.40%
ABMD - Net Income
🔓 See the full chart40% off right now · 7-day free trial
ABMD Net Income CAGR:1Y: 86.35%2Y: 30.61%5Y: 34.07%10Y: 34.52%
ABMD - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
ABMD EBITDA CAGR:1Y: -2.57%2Y: -0.35%5Y: 13.87%10Y: 25.78%
ABMD - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
ABMD Free Cash Flow CAGR:1Y: -85.36%2Y: -66.03%5Y: -26.03%10Y: 3.27%
ABMD - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
ABMD Free Cash Flow / Share CAGR:1Y: -85.34%2Y: -66.13%5Y: -26.44%10Y: 1.83%
ABMD - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
ABMD Operating Income CAGR:1Y: -4.04%2Y: -2.76%5Y: 12.82%10Y: 25.61%
ABMD - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
ABMD Gross Profit CAGR:1Y: 6.26%2Y: 12.65%5Y: 14.31%10Y: 21.79%
ABMD - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
ABMD Shares Outstanding CAGR:1Y: -0.40%2Y: 0.05%5Y: 0.01%10Y: 0.92%
ABMD - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
ABMD Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABMD - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
ABMD Stock-Based Comp CAGR:1Y: 1.68%2Y: 17.67%5Y: 11.52%10Y: 0.00%
ABMD - Expenses
🔓 See the full chart40% off right now · 7-day free trial
ABMD Expenses CAGR:1Y: -22.36%2Y: -23.19%5Y: -6.55%10Y: 17.14%
ABMD - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
ABMD - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
ABMD - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
ABMD - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
ABMD - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
ABMD - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
ABMD - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
ABMD Revenue CAGR:1Y: 7.16%2Y: 12.59%5Y: 14.89%10Y: 21.67%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ABMD - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
ABMD Actual Revenue CAGR:1Y: 7.16%2Y: 12.59%5Y: 14.89%10Y: 21.67%
ABMD - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
ABMD Actual EPS CAGR:1Y: 87.10%2Y: 30.61%5Y: 33.85%10Y: 33.40%
ABMD - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
ABMD Actual Net Income CAGR:1Y: 86.35%2Y: 30.61%5Y: 34.07%10Y: 34.52%
ABMD - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
ABMD Actual EBITDA CAGR:1Y: -2.57%2Y: -0.35%5Y: 13.87%10Y: 25.78%

Ratios, Profit Margins & Return on Capital:

ABMD - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
ABMD Net Profit Margin CAGR:1Y: 73.90%2Y: 16.00%5Y: 16.69%10Y: 10.56%
ABMD - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
ABMD Gross Profit Margin CAGR:1Y: -0.84%2Y: 0.06%5Y: -0.51%10Y: 0.10%
ABMD - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
ABMD Price to Earnings CAGR:1Y: -59.56%2Y: -27.69%5Y: -19.14%10Y: -3.61%
ABMD - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
ABMD Price To Sales Ratio CAGR:1Y: -29.68%2Y: -16.12%5Y: -5.64%10Y: 6.58%
ABMD - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
ABMD Return on Capital Employed CAGR:1Y: -13.04%2Y: -13.98%5Y: -5.88%10Y: -0.89%
ABMD - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
ABMD Return on Invested Capital CAGR:1Y: -21.97%2Y: -17.38%5Y: -5.65%10Y: -2.87%

Compare stocks side-by-side

Projected Future Returns & Dividends for ABMD

Based on past 10-year performance, here are ABMD growth metrics:

Share price CAGR of +39.59%
Dividend CAGR of +0%

Using ABMD CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

ABMD (DRIP)ABMD - No DRIP
Current Price$381.02$381.02
Start Shares26.2526.25
Start Value$10,000$10,000
  
After 10 years:
Final Share Count26.2526.25
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$381.02$381.02
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - ABMD

NOTE: Above numbers are our estimate based on ABMD's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

Abiomed, Inc. (ABMD) had its IPO on 1987-07-29, and is traded on NASDAQ stock exchange.

Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while also offering ongoing care for these individuals. Its product portfolio includes various devices from the Impella family. The Impella 2.5 is a tiny percutaneous heart pump featuring an integrated motor and sensors, alongside the Impella CP, which is utilized by interventional cardiologists in catheterization labs and by cardiac surgeons during operations. Other Impella models such as the 5.0, LD, and 5.5 are also percutaneous micro heart pumps, primarily employed in surgical settings. The Impella RP is a percutaneous catheter-based axial flow pump. Beyond the pumps, Abiomed offers the Impella SmartAssist platform, which leverages optical sensors for precise pump placement and uses algorithms to enhance native heart function assessment during patient weaning. Its Impella Connect system provides secure, cloud-based remote monitoring of the automated Impella controller for medical staff. The company also markets the OXY-1 System, a portable device for external respiratory support. Furthermore, Abiomed is actively developing several innovations, including the Impella ECP pump for high blood flow rates, the Impella XR Sheath for smaller access during Impella procedures, the Impella BTR percutaneous micro heart pump, and preCARDIA, a catheter-based superior vena cava therapy system aimed at quickly addressing acute decompensated heart failure. Abiomed distributes its products globally through its dedicated direct sales and clinical support teams, reaching regions such as the United States, Japan, Canada, countries across Europe (including Germany and France), Latin America, the Asia-Pacific, and the Middle East. Founded in 1981 and headquartered in Danvers, Massachusetts, Abiomed, Inc. has been operating as a subsidiary of Johnson & Johnson since December 22, 2022.

ABMD website: https://www.abiomed.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — ABMD

Value from:
Pay up to today
—
vs current price $381.02
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →